Complete Filing Data
Adagene Inc. reported Stockholders Equity of $50.52 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Adagene Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$33.4M | -$18.9M | -$80.0M | -$73.2M | -$42.4M | -$16.4M | -$15.3M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$33.4M | -$17.3M | -$79.5M | -$71.5M | -$42.4M | -$16.4M | -$15.3M |
| Research And Development Expense | $28.8M | $36.6M | $81.3M | $68.1M | $33.5M | $16.2M | $16.1M |
| Other Nonoperating Income | $466.6K | $1.8M | $2.2M | $1.8M | $971.9K | $723.5K | $901.7K |
| Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $1.3M | -$950.8K | -$755.3K | $257.0K | -$6.1K | $65.8K | -$11.3K |
| Operating Income Loss | -$36.0M | -$23.7M | -$83.9M | -$72.4M | -$43.2M | -$19.2M | -$17.3M |
| Net Income Loss Available To Common Stockholders Basic | -$33.4M | -$18.9M | -$80.0M | -$73.2M | -$42.6M | -$16.7M | -$14.3M |
| General And Administrative Expense | $7.3M | $8.7M | $11.9M | $14.4M | $10.3M | $3.4M | $2.8M |
| Comprehensive Income Net Of Tax | -$32.2M | -$19.9M | -$80.7M | -$72.9M | -$42.4M | -$16.4M | -$15.3M |
| Research And Development Expense Third Parties | $26.8M | $34.0M | $46.2M | $55.0M | $23.6M | $10.5M | $8.6M |
| Related Party Transaction Research And Development Expense From Transactions With Related Party | $1.9M | $2.7M | $35.1M | $13.1M | $9.9M | $5.7M | $7.5M |
| Revenue From Contract With Customer Excluding Assessed Tax | $103.2K | $18.1M | $9.3M | $10.2M | $700.9K | $480.0K | $1.5M |
| Interest Expense | $1.1M | $693.3K | $363.8K | $202.2K | $138.1K | $91.1K | |
| Income Tax Expense Benefit | -$17.6K | $1.7M | $459.1K | $1.7M | |||
| Investment Income Nonoperating | $4.3M | $377.5K | $76.2K | $629.3K | $922.7K | $710.7K | |
| Income Taxes Paid Net | $33.9K | $1.4M | $2.4M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $50.5M | $70.6M | $83.1M | $156.6M | -$89.4M | -$57.0M | -$41.0M | -$25.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $85.2M | $109.9M | $143.8M | $174.4M | $75.2M | $92.5M | $16.1M | $8.7M |
| Repayments Of Debt | $8.3M | $13.5M | $4.4M | $5.1M | $1.1M | $2.4M | $1.4M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$24.7M | -$33.8M | -$30.6M | $99.2M | -$17.4M | $76.5M | $7.3M | |
| Short Term Bank Loans And Notes Payable | $4.9M | $4.2M | $10.8M | $3.1M | $3.8M | $716.7K | ||
| Retained Earnings Accumulated Deficit | -$311.2M | -$277.8M | -$258.8M | -$178.8M | -$105.7M | -$63.3M | ||
| Property Plant And Equipment Net | $1.1M | $1.8M | $2.8M | $3.5M | $2.1M | $1.9M | ||
| Prepaid Expense And Other Assets Current | $2.6M | $3.3M | $4.9M | $4.1M | $3.8M | $1.5M | ||
| Other Assets Noncurrent | $81.4K | $84.9K | $109.6K | $69.3K | $3.1M | $87.2K | ||
| Long Term Debt Current | $12.9M | $4.2M | $2.9M | $1.4M | $1.2M | $322.5K | ||
| Liabilities Current | $38.2M | $31.5M | $55.1M | $29.8M | $16.1M | $7.2M | ||
| Liabilities And Stockholders Equity | $89.3M | $115.7M | $152.4M | $189.5M | $84.3M | $105.9M | ||
| Liabilities | $38.7M | $45.2M | $69.3M | $33.0M | $19.2M | $8.7M | ||
| Common Stock Value | $5.9K | $5.5K | $5.5K | $5.6K | $1.9K | $1.5K | ||
| Cash And Cash Equivalents At Carrying Value | $85.2M | $109.9M | $143.8M | $174.4M | $75.2M | $92.5M | ||
| Assets Current | $87.8M | $113.4M | $149.3M | $186.0M | $79.1M | $103.9M | ||
| Assets | $89.3M | $115.7M | $152.4M | $189.5M | $84.3M | $105.9M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$526.9K | -$1.8M | -$849.3K | -$94.0K | -$351.0K | -$344.9K | ||
| Accrued Liabilities And Other Current Liabilities | $2.8M | $3.0M | $3.2M | $4.4M | $6.1M | $2.5M | ||
| Accounts Payable Current | $4.2M | $3.1M | $3.7M | $3.3M | $1.8M | $712.7K | ||
| Long Term Debt Noncurrent | $417.3K | $13.5M | $14.1M | $3.0M | $3.0M | $1.5M | ||
| Gain Loss On Sale Of Property Plant Equipment And Operating Lease Right Of Use Asset | $2.5K | $9.4K | $6.8K | $19.0K | $327.00 | |||
| Operating Lease Right Of Use Asset And Interest Of Lease Liabilities Amortization Expense | $215.9K | $228.4K | $303.5K | |||||
| Operating Lease Payments | $216.6K | $225.5K | $313.9K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $4.9M | $7.3M | $10.5M | $18.7M | $10.1M | $611.7K | $126.5K |
| Payments To Acquire Productive Assets | $33.6K | $85.0K | $690.9K | $2.5M | $935.2K | $151.8K | $514.7K |
| Net Cash Provided By Used In Operating Activities | -$29.7M | -$28.5M | -$48.6M | -$43.4M | -$28.5M | -$18.2M | -$14.3M |
| Net Cash Provided By Used In Investing Activities | $1.1M | -$77.4K | -$686.0K | -$2.5M | $7.1M | $24.9M | -$29.5M |
| Net Cash Provided By Used In Financing Activities | $3.8M | -$5.4M | $17.8M | $145.4M | $4.4M | $69.7M | $51.1M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$724.2K | -$1.6M | $881.4K | $231.3K | $2.3M | -$111.5K | $1.3M |
| Increase Decrease In Other Noncurrent Assets | -$3.5K | -$24.7K | $40.3K | $24.2K | $13.3K | $38.0K | $28.8K |
| Increase Decrease In Due To Related Parties | -$3.5M | -$2.6M | $8.9M | $7.9M | $639.6K | -$1.8M | $2.1M |
| Increase Decrease In Due From Related Parties | -$213.7K | -$397.4K | -$3.9M | $4.4M | -$1.3M | $704.3K | -$268.7K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$185.5K | -$122.2K | -$823.9K | $1.1M | $1.2M | -$34.3K | -$913.5K |
| Increase Decrease In Accounts Payable | $1.1M | -$572.4K | $344.5K | $1.5M | $1.1M | $153.7K | $389.1K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $81.9K | $74.7K | $842.2K | -$192.4K | -$364.2K | $77.5K | $38.7K |
| Depreciation Depletion And Amortization | $723.0K | $980.1K | $1.1M | $1.1M | $858.4K | $816.7K | $909.0K |
| Proceeds From Stock Options Exercised | $178.3K | $5.5K | $323.2K | $231.5K | $140.9K | $459.8K | |
| Proceeds From Issuance Of Debt | $4.9M | $8.1M | $25.8M | $4.4M | $6.1M | $2.7M | $2.4M |
| Increase Decrease In Contract With Customer Liability | -$15.1M | $9.6M | $4.8M | -$267.8K | $993.4K | ||
| Proceeds From Sale Of Short Term Investments | $129.6M | $47.0M | $8.0M | $44.0M | $29.0M | ||
| Proceeds From Sale Of Productive Assets | $169.00 | $7.7K | $4.9K | $7.9K | $7.7K | $5.2K | |
| Increase Decrease In Accrued Income Taxes Payable | -$47.6K | $52.9K | -$1.7M | $1.7M | |||
| Stock Issued During Period Value Share Based Compensation | $4.9M | $7.3M | $10.5M | $416.8K | |||
| Increase Decrease In Accounts Receivable | -$3.0M | $3.0M | -$480.0K | $480.0K | |||
| Payments To Acquire Short Term Investments | $128.5M | $47.0M | $19.0M | $58.0M | |||
| Increase Decrease In Other Noncurrent Liabilities | -$28.4K | -$29.7K | $92.0K | -$142.1K | |||
| Increase Decrease In Operating Lease Liability | -$220.5K | -$237.4K | -$280.5K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Diluted Shares Outstanding | 56.3M | 54.7M | 54.1M | 50.0M | 16.0M | 15.2M | 15.2M |
| Earnings Per Share Diluted | $-0.59 | $-0.35 | $-1.48 | $-1.46 | $-2.67 | $-1.10 | $-0.94 |
| Weighted Average Number Of Shares Outstanding Basic | 56.3M | 54.7M | 54.1M | 50.0M | 16.0M | 15.2M | 15.2M |
| Earnings Per Share Basic | $-0.59 | $-0.35 | $-1.48 | $-1.46 | $-2.67 | $-1.10 | $-0.94 |
| Common Stock Shares Outstanding | 58.9M | 55.1M | 54.1M | 54.6M | 16.6M | 15.2M | |
| Common Stock Shares Issued | 58.9M | 55.1M | 54.1M | 54.6M | 16.6M | 15.2M | |
| Common Stock Shares Authorized | 640.0M | 640.0M | 640.0M | 640.0M | 640.0M | 500.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Interest Paid Net | $778.5K | $1.0M | $603.7K | $359.6K | $202.2K | $142.1K | $91.1K |
| Foreign Currency Transaction Gain Loss Before Tax | -$906.2K | $1.4M | $2.6M | -$603.5K | -$644.7K | $21.9K | $12.7K |
| Stock Issued During Period Value Stock Options Exercised | $190.2K | $5.5K | $323.2K | $226.8K | $140.9K | $18.7K | |
| Stock Issued During Period Shares Stock Options Exercised | 185.6K | 10.0K | 198.0K | 234.0K | 3.7M | 34.0K | |
| Additional Paid In Capital | $362.2M | $350.1M | $342.7M | $336.1M | $23.8M | $6.8M | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $10.5M | $18.7M | $10.1M | $611.7K | $126.5K |
Most recent annual filing with the SEC: March 24, 2025
Data sourced from SEC EDGAR public filings as of August 6, 2026.